200 related articles for article (PubMed ID: 32427576)
1. miR-125a-5p inhibits glycolysis by targeting hexokinase-II to improve pulmonary arterial hypertension.
Luo L; Xiao L; Lian G; Wang H; Xie L
Aging (Albany NY); 2020 May; 12(10):9014-9030. PubMed ID: 32427576
[TBL] [Abstract][Full Text] [Related]
2. MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways.
Cai Z; Li J; Zhuang Q; Zhang X; Yuan A; Shen L; Kang K; Qu B; Tang Y; Pu J; Gou D; Shen J
Exp Mol Med; 2018 Apr; 50(4):1-11. PubMed ID: 29700287
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-140-5p targeting tumor necrosis factor-α prevents pulmonary arterial hypertension.
Zhu TT; Zhang WF; Yin YL; Liu YH; Song P; Xu J; Zhang MX; Li P
J Cell Physiol; 2019 Jun; 234(6):9535-9550. PubMed ID: 30367500
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of miR-135a-5p promotes the development of rat pulmonary arterial hypertension in vivo and in vitro.
Liu HM; Jia Y; Zhang YX; Yan J; Liao N; Li XH; Tang Y
Acta Pharmacol Sin; 2019 Apr; 40(4):477-485. PubMed ID: 30038339
[TBL] [Abstract][Full Text] [Related]
5. MiR-18a-5p contributes to enhanced proliferation and migration of PASMCs via targeting Notch2 in pulmonary arterial hypertension.
Miao R; Liu W; Qi C; Song Y; Zhang Y; Fu Y; Liu W; Lang Y; Zhang Y; Zhang Z
Life Sci; 2020 Sep; 257():117919. PubMed ID: 32585247
[TBL] [Abstract][Full Text] [Related]
6. In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression.
Le Ribeuz H; Courboulin A; Ghigna MR; Lambert M; Hautefort A; Humbert M; Montani D; Cohen-Kaminsky S; Perros F; Antigny F
Respir Res; 2020 Jul; 21(1):186. PubMed ID: 32678044
[TBL] [Abstract][Full Text] [Related]
7. MiR-125a regulates mitochondrial homeostasis through targeting mitofusin 1 to control hypoxic pulmonary vascular remodeling.
Ma C; Zhang C; Ma M; Zhang L; Zhang L; Zhang F; Chen Y; Cao F; Li M; Wang G; Shen T; Yao H; Liu Y; Pan Z; Song S; Zhu D
J Mol Med (Berl); 2017 Sep; 95(9):977-993. PubMed ID: 28593577
[TBL] [Abstract][Full Text] [Related]
8. 3-Bromopyruvate reverses hypoxia-induced pulmonary arterial hypertension through inhibiting glycolysis: In vitro and in vivo studies.
Chen F; Wang H; Lai J; Cai S; Yuan L
Int J Cardiol; 2018 Sep; 266():236-241. PubMed ID: 29735421
[TBL] [Abstract][Full Text] [Related]
9. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
10. miR-181a/b-5p ameliorates inflammatory response in monocrotaline-induced pulmonary arterial hypertension by targeting endocan.
Zhao H; Guo Y; Sun Y; Zhang N; Wang X
J Cell Physiol; 2020 May; 235(5):4422-4433. PubMed ID: 31637717
[TBL] [Abstract][Full Text] [Related]
11. MiR-593-5p promotes the development of hypoxic-induced pulmonary hypertension via targeting PLK1.
Zhao TF; Wang SY; Zou XZ; Zhao HD
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3495-3502. PubMed ID: 31081105
[TBL] [Abstract][Full Text] [Related]
12. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis.
Ding Z; Guo L; Deng Z; Li P
Ann Hepatol; 2020; 19(3):269-279. PubMed ID: 32089501
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway.
Zhang Y; Liu Y; Xu X
J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500
[TBL] [Abstract][Full Text] [Related]
14. Cold exposure aggravates pulmonary arterial hypertension through increased miR-146a-5p, miR-155-5p and cytokines TNF-α, IL-1β, and IL-6.
Sánchez-Gloria JL; Carbó R; Buelna-Chontal M; Osorio-Alonso H; Henández-Díazcouder A; de la Fuente-León RL; Sandoval J; Sánchez F; Rubio-Gayosso I; Sánchez-Muñoz F
Life Sci; 2021 Dec; 287():120091. PubMed ID: 34717910
[TBL] [Abstract][Full Text] [Related]
15. MiR-140-5p regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and differentiation by targeting Dnmt1 and promoting SOD2 expression.
Zhang Y; Xu J
Biochem Biophys Res Commun; 2016 Apr; 473(1):342-348. PubMed ID: 27021683
[TBL] [Abstract][Full Text] [Related]
16. MiR-216a-5p/Hexokinase 2 axis regulates uveal melanoma growth through modulation of Warburg effect.
Liu Y; Huo Y; Wang D; Tai Y; Li J; Pang D; Zhang Y; Zhao W; Du N; Huang Y
Biochem Biophys Res Commun; 2018 Jul; 501(4):885-892. PubMed ID: 29763606
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of miR-4640-5p alleviates pulmonary hypertension in chronic obstructive pulmonary disease patients by regulating nitric oxide synthase 1.
Yang Z; Li P; Yuan Q; Wang X; Ma HH; Zhuan B
Respir Res; 2023 Mar; 24(1):92. PubMed ID: 36964568
[TBL] [Abstract][Full Text] [Related]
18. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
Zhu X; Du J; Gu Z
Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
[TBL] [Abstract][Full Text] [Related]
19. 3-Bromopyruvate alleviates the development of monocrotaline-induced rat pulmonary arterial hypertension by decreasing aerobic glycolysis, inducing apoptosis, and suppressing inflammation.
Liu J; Wang W; Wang L; Qi XM; Sha YH; Yang T
Chin Med J (Engl); 2020 Jan; 133(1):49-60. PubMed ID: 31923104
[TBL] [Abstract][Full Text] [Related]
20. Mir-455-3p-1 represses FGF7 expression to inhibit pulmonary arterial hypertension through inhibiting the RAS/ERK signaling pathway.
Zhou C; Chen Y; Kang W; Lv H; Fang Z; Yan F; Li L; Zhang W; Shi J
J Mol Cell Cardiol; 2019 May; 130():23-35. PubMed ID: 30858037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
